Table 4.
Bivariate analysis of factors associated with CVD mortality risk
| Variables | Total (N = 144) | < 5.00% | 5.00–9.90% | 10.00–19.90% | 20.00–29.90% | > 30.00% | P value |
|---|---|---|---|---|---|---|---|
| Black Africans | 133 | 71 (53.38) | 24 (18.05) | 23 (17.29) | 9 (6.77) | 6 (4.51) | < 0.001Ϯ |
| Other racesα | 11 | 4.0 (36.36) | 2 (18.18) | – | – | 5 (45.45) | |
| 1st line regimen | 73 | 37 (50.68) | 13 (17.81) | 16 (21.92) | 4 (5.48) | 3 (4.11) | 0.211* |
| 2nd line regimen | 70 | 37 (52.86) | 13 (18.57) | 7 (10) | 5 (7.14) | 8 (11.43) | |
| Previous tuberculosis | 70 | 44 (62.86) | 8 (11.43) | 11 (15.71) | 4 (5.71) | 3 (4.29) | 0.063Ϯ |
| No tuberculosis | 72 | 30 (41.67) | 18 (25.00) | 11 (15.28) | 5 (6.94) | 8 (11.11) |
ϮFisher’s exact test; * Pearson Chi square (χ2) test, α Coloured and White